Published June 8, 2022 | Version v1
Journal article Open

INCIDENCE AND PREVALENCE OF MUCORMYCOSIS IN COVID -19 PATIENTS WITH COMORBID CONDITIONS IN TERTIARY CARE HOSPITAL

Description

Aim: The aim of the study carried out was to check the Incidence and prevalence of Mucormycosis in covid-19 patients with comorbid conditions.

Methodology: This is the retrospective observational study conducted in the In-patient department of the Covid-19 ward at Aware Global Hospital and Govt. ENT Hospital, the relevant data on the Drug prescription of each patient was collected from Medical Record Department, patient age, sex, diagnosis, treatment, drugs, doses of drugs, frequency of drugs, and route of administration were collected.

Results: A total number of 100 patients with mucormycosis were enrolled in the study, of which 80 were male patients and there were 20 female patients. The study revealed that hypertension is the second leading factor for Covid-19 associated with Mucormycosis. 1/4th of the patients have developed Denovo diabetes due to administration of steroids, were as 1/5th of the patients have both diabetes and hypertension.

Conclusion: The study concludes that most of the patients with a history of diabetes and hypertension were detected during the study period. Mostly males were affected, due to over usage of steroids few patients are affected with Denovo diabetes.

Files

13.project journal (2).pdf

Files (652.2 kB)

Name Size Download all
md5:4b66d4af4058a11aefd09d71313a6900
652.2 kB Preview Download